Items tagged with Access
Price announced for new lifesaving TB drug pretomanid still too high (post with simple image)
Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.
Civil society statement on rifapentine price discount (post with simple image)
A lower price for rifapentine is just a start — communities need more than discounts to access TB preventive therapy!
Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5 (post with simple image)
The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.
Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson (post with simple image)
Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.
TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs (post with simple image)
Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.
TB Alliance responds to questions raised by activists in relation to pretomanid (post with simple image)
MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.
Stop TB Partnership launches the TB Stigma Assessment Tool (post with simple image)
The Tool aims to assess the extent to which and how TB stigma acts as a barrier to accessing services and to support the development of recommendations to address TB stigma so that quality TB services are available, accessible and acceptable to all.
Stop TB Partnership launches the Challenge Facility for Civil Society 2019 (post with simple image)
The largest-ever call for proposals for community and civil society for a TB response that is rights-based, gender-transformative, people-centered and accountable is announced.
Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia (post with simple image)
Activists urge Sanofi to do the same in other countries.
MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)
Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.
Page 74 of 82 · Total posts: 0
←First 73 74 75 Last→